Abstract PD11-01: PD11-01 Evaluation of the PD-1 Inhibitor Cemiplimab in Early-Stage, High-Risk HER2-negative Breast Cancer: Results from the Neoadjuvant I-SPY 2 TRIAL Erica Stringer-Reasor , Rebecca A. Shatsky , Jo Chien , Anne Wallace , Judy C. Boughey , Kathy S. Albain , Hyo S. Han , Rita Nanda , Claudine Isaacs , Kevin Kalinsky , Zahi Mitri , Amy S. Clark , Christos Vaklavas , Alexandra Thomas , Meghna S. Trivedi , Janice Lu , Smita Asare , Ruixiao Lu , Maria Pitsouni , Amy Wilson , Jane Perlmutter , Hope Rugo , Richard Schwab , W. Fraser Symmans , Nola M. Hylton , Laura Van ’t Veer , Douglas Yee , Angela DeMichele , Donald Berry , Laura J. Esserman , I-SPY Investigators Cancer Research（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
